Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateCaliforniaIn Committee
SB 1224: The California Emerging Therapies Research Partnership Act.
Brian Jones
SB 1224 status: In Committee — From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 30). Re-referred to Com. on APPR (updated Jul 1, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
73OUT OF 100
Score:73/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality95%
Bipartisan80%
Public opinion70%
Bill summary
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of substances placed in Schedule I. Existing law classifies, among others, psilocybin, ibogaine, and dimethyltryptamine as Schedule I substances, classifies ketamine as a Schedule III substance, and prohibits various actions related to those substances, including their sale, possession, transportation, manufacture, or c...
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
65%
Benefits
- Enables capture of significant federal ARPA-H research funds
- Supports job creation through increased clinical trial activity
- Provides home protection companies with flexibility for cost-effective claims
Risks
- Creates uncertainty regarding the sustainability of the partnership fund
- May limit repair/replacement options for home warranty consumers
- Requires ongoing administrative expenditures for fund management
Society
Positive outlook
75%
Benefits
- Targets clinical research for veteran PTSD and substance abuse
- Provides institutional oversight for emerging medical therapies
- Prioritizes treatment research for high-need veteran populations
Risks
- Limits therapy access to restricted, research-controlled settings
- Does not address broader public access to emerging treatments
- Risk of disparity in outcomes between trial participants and non-participants
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
75%
Benefits
- Mandates progress reports to the Legislature on federal funding
- Establishes a dedicated advisory council for veteran input
- Requires legislative committee briefing rights for ongoing oversight
Risks
- Administrative overhead for advisory council management
- Reporting requirements may place strain on agency staff
- Potential for 'readiness reports' to become administrative formalities
Public Health & Safety
Positive outlook
75%
Benefits
- Advances high-potential psychedelic research for treatment-resistant conditions
- Provides rigorous FDA-compliant framework for Schedule I substances
- Supports veteran mental health safety protocols and needs assessments
Risks
- Inherent clinical risks associated with experimental psychedelic trials
- Strict regulatory requirements may slow research progression
- Privacy risks regarding clinical data-sharing protocols
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
The clinical use of Schedule I substances, even in research, poses inherent safety risks that are strictly contingent upon federal and state compliance.
Analysis scope
Specifics of the federal partnership agreements remain subject to ongoing federal negotiations.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.